Charleston-based Coastal Pediatric Analysis has been chosen by Moderna to conduct their pediatric COVID-19 vaccine trials.
The one South Carolina website to have been awarded the just lately closed-to-enrollment 12–17-year-old trial, Coastal Pediatric Analysis is now accepting registration purposes for potential candidates within the six-months to 11-year age group.
Principal investigator, Dr. Robert Cliﬀord, stated, “Whereas solely a part of the equation, pediatric vaccine analysis and improvement is integral to combating the 2019 novel coronavirus pandemic. As the worldwide analysis neighborhood works collectively to find out the easiest way to guard our kids, we’re inspired by the enthusiastic response from Lowcountry mother and father.”
Clifford emphasised that all through the COVID-19 pandemic Coastal Pediatric Associates teammates labored arduous to look after these aﬀected by SARS-CoV-2, whereas additionally attempting to mitigate contagion throughout the neighborhood. “Not restricted to these throughout the Coastal Pediatric Associates household, our analysis trials are open to all kids within the Lowcountry space,” he stated.
Coastal Pediatric Associates Pediatricians and Coastal Pediatric Analysis Medical Administrators, Drs. Robert Cliﬀord and Stephen Stripling, together with their crew of analysis investigators, will conduct evaluations of potential topics to find out eligibility for research participation. Preregistration for the six-months to age 11 Moderna trial started March 1.
In keeping with Dr. Stripling, “Coastal Pediatric Analysis investigators and staﬀ are devoted to ﬁnding a vaccine that works throughout all age teams. Past our work within the pediatric neighborhood, we’re equally excited to be partnering with Pﬁzer and Lowcountry obstetricians to assist decide the protection and eﬃcacy of their COVID vaccine in pregnant ladies.”